Few practices in reproductive medicine are as widely accepted yet as poorly evidenced as the cancellation of embryo transfer for thin endometrium. The lecture proposes a logical framework — four sequential questions — that must all be answered convincingly before cancellation can be justified. None of the four, on closer examination, holds up.
There is no biological consensus on the threshold. The literature cutoffs span 6 to 14 mm, with the widely-quoted 7 mm threshold tracing back to a small cohort study from the late 1980s, when vaginal ultrasound was not yet standard and sample sizes were modest. Live births at thickness below 4 mm have been published. The threshold is convention, not biology.
Two opposing pathophysiological theories coexist in the literature. One holds that thin endometrium reflects poor vascularisation and low oxygen — bad for the embryo. The other holds that thin endometrium places the embryo too close to the basal layer, causing hyperoxia and oxidative damage — also bad for the embryo. Neither has been demonstrated convincingly, and they point in opposite mechanistic directions.
Thickness studies suffer from inconsistent measurement timing (trigger day vs OPU vs ET), inflated statistical significance from massive registry sample sizes that translate to clinically trivial effect sizes, and severe practice-pattern contamination — units that already cancel thin endometrium do not contribute thin cases to the denominator. Inter-observer measurement variability of several millimetres further undermines the precision needed for clinical thresholds.
No therapy currently in clinical use has been shown to reliably increase endometrial thickness with a corresponding live-birth gain. Patients are often subjected to repeated «endo prep» cycles without any proven intervention — losing time and emotional investment without measurable benefit.
Prospective and multicentre data — including a large multicentre study of euploid blastocyst transfers — show that when transfer proceeds regardless of thickness (after excluding intracavitary pathology and premature progesterone exposure), live birth rates at <7 mm remain in the 42–47% range. Cancellation guarantees zero. Proceeding offers a substantial probability of pregnancy.
Replace mm-based cancellation rules with a structured exclusion checklist: intracavitary pathology, scarring, infection and premature progesterone exposure. If these are addressed, the residual «thinness» does not justify cancellation. Counsel patients with realistic outcome data, not with mm-thresholds inherited from the 1980s.
Thin endometrium remains one of the most debated topics in reproductive medicine. Is it justified to cancel transfer at a thickness of <7 mm? Analysis of the evidence base — from classical work of the late 1980s to current multicentre cohorts (~30,000 cycles) — shows that with proper work-up (exclusion of intracavitary pathology and premature progesterone exposure), the live birth rate at thickness <7 mm remains in the 42–47% range.
Thin endometrium remains one of the most debated topics in reproductive medicine. Is it justified to cancel transfer at a thickness of <7 mm? Analysis of the evidence base — from classical work of the late 1980s to current multicentre cohorts (~30,000 cycles) — shows that with proper work-up (exclusion of intracavitary pathology and premature progesterone exposure), the live birth rate at thickness <7 mm remains in the 42–47% range.
Cancellation is only justified when all four prerequisite questions are convincingly answered yes.
Recognise that 6–14 mm cutoffs in literature reflect practice patterns, not biology.
Single-millimetre thresholds are not reproducible enough to drive clinical decisions.
Live birth rate at <7 mm remains in the 42–47% range with proper exclusion of pathology.
Dean of Koç University School of Medicine, and Professor and Head of its Department of Obstetrics and Gynecology. A reproductive endocrinology and infertility subspecialist focusing on female infertility, IVF and endometriosis. Holds leadership positions in international fertility societies and serves as an editor for international journals.
Author of the lecture "Thin endometrium — should embryo transfer be cancelled?"
